text.skipToContent text.skipToNavigation
  • Cross.svg
    Extensive product ranges
Calling 01685 846666

Prolia denosumab 60mg/1ml solution for injection in pre-filled syringe POM X1

ID:J1406 , 3544756
Pharmaceutical Product
In Stock
  • Product Requires Refrigeration

Important Notice: Pharma products are sold and shipped exclusively to registered medical professionals at verified medical premises. 

Non-approved buyers: Complete our Online POM Form, and we will notify you once your account is Pharma approved.


What is Prolia?:
 
Prolia contains denosumab, a protein (monoclonal antibody) that interferes with the action of another protein, in order to treat bone loss and osteoporosis. Treatment with Prolia makes bone stronger and less likely to break.

 

Bone is a living tissue and is renewed all the time. Oestrogen helps keep bones healthy. After the menopause, oestrogen level drops which may cause bones to become thin and fragile. This can eventually lead to a condition called osteoporosis. Osteoporosis can also occur in men due to a number of causes including ageing and/or a low level of the male hormone, testosterone. It can also occur in patients receiving glucocorticoids. Many patients with osteoporosis have no symptoms, but they are still at risk of breaking bones, especially in the spine, hips and wrists.

 

Surgery or medicines that stop the production of oestrogen or testosterone used to treat patients with breast or prostate cancer can also lead to bone loss. The bones become weaker and break more easily.                                                                      
                                                                                                  Patient info leaflet link:

 

   Microsoft Word - gb_prolia_approved_pil_eualignv99_cdsv29                              

Specs
Reviews
Downloads